A Trial of All-trans Retinoic Acid (ATRA) in Advanced Adenoid Cystic Carcinoma
Clinical trial NCT03999684 · COMPLETED
Trial details
- NCT number
- NCT03999684
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-05
- Primary completion
- 2020-04-15
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.